BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20265166)

  • 1. British anti-lewisite; its use and therapeutic value in arsenical intoxications.
    PETERS RA; BENNET J
    Lancet; 1947 Oct; 2(6475):497. PubMed ID: 20265166
    [No Abstract]   [Full Text] [Related]  

  • 2. British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.
    PETERS RA; BENNET J
    Br Med J; 1947 Oct; 2(4526):520. PubMed ID: 20267003
    [No Abstract]   [Full Text] [Related]  

  • 3. [B.A.L treatment of arsenical poisoning].
    MIGNOLET F; HEUSGHEM C; BACQ ZM
    Acta Clin Belg; 1947; 2():199-204. PubMed ID: 20269203
    [No Abstract]   [Full Text] [Related]  

  • 4. The fate of arsenical vesicants in the skin and the effect of BAL (British anti-lewisite).
    Graham AF; Levvy GA; Chance AC
    Biochem J; 1947; 41(3):352-7. PubMed ID: 16748172
    [No Abstract]   [Full Text] [Related]  

  • 5. British anti-lewisite; antidotal effects against therapeutic arsenicals.
    STOCKEN LA; THOMPSON RH; WHITTAKER VP
    Biochem J; 1947; 41(1):47-52. PubMed ID: 20287850
    [No Abstract]   [Full Text] [Related]  

  • 6. British anti-lewisite. I. The biochemistry of arsenic.
    PETERS RA
    J R Inst Public Health; 1952 Apr; 15(4):89-103. PubMed ID: 14918249
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of lewisite and other arsenical vesicant lesions of the eyes of rabbits with British anti-lewisite (BAL).
    MANN I; PIRIE A; PULLINGER BD
    Am J Ophthalmol; 1947 Apr; 30(4):421-35. PubMed ID: 20256316
    [No Abstract]   [Full Text] [Related]  

  • 8. British anti-lewisite; arsenic and thiol excretion in animals after treatment of lewisite burns.
    STOCKEN LA; THOMPSON RH
    Biochem J; 1946 Jul; 40(4):548-54. PubMed ID: 20273640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical injury in arsenical intoxication and the British Anti-Lewisite].
    PETERS RA
    Rev Med Liege; 1948 Dec; 3(23):687-98. PubMed ID: 18100780
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic distribution in rabbits after Lewisite administration and treatment with British anti-Lewisite (BAL).
    Snider TH; Wientjes MG; Joiner RL; Fisher GL
    Fundam Appl Toxicol; 1990 Feb; 14(2):262-72. PubMed ID: 2318351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bal (British anti-lewisite).
    WATERS LL; STOCK C
    Science; 1945 Dec; 102(2658):601-6. PubMed ID: 21004953
    [No Abstract]   [Full Text] [Related]  

  • 13. British anti-lewisite (BAL).
    PETERS RA; STOCKEN LA; THOMPSON RH
    Nature; 1945; 156():616-9. PubMed ID: 21006485
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical uses of 2,3-dimercaptopropanol (BAL); the effect of BAL on the excretion of arsenic in arsenical intoxication.
    LUETSCHER JA; EAGLE H; LONG-COPE WT
    J Clin Invest; 1946 Jul; 25(4):534-40. PubMed ID: 21001627
    [No Abstract]   [Full Text] [Related]  

  • 15. [BAL in the treatment of intoxication by arsenical and gold preparations].
    BERMUDEZ ABREU VP
    Rev Kuba Med Trop Parasitol; 1950; 6(3-4):59-65. PubMed ID: 15441436
    [No Abstract]   [Full Text] [Related]  

  • 16. The therapeutic effects of British anti-lewisite (BAL) on tissue cultures grown in a medium containing lewisite oxide.
    FELL HB; ALLSOPP CB
    Br J Exp Pathol; 1946 Oct; 27(5):310-5. PubMed ID: 20279216
    [No Abstract]   [Full Text] [Related]  

  • 17. BALINTRAV; a new non-toxic thiol for intravenous injection in arsenical poisoning.
    DANIELLI JF; DANIELLI M
    Biochem J; 1947; 41(3):325-33. PubMed ID: 20266508
    [No Abstract]   [Full Text] [Related]  

  • 18. British anti-Lewisite (dimercaprol): an amazing history.
    Vilensky JA; Redman K
    Ann Emerg Med; 2003 Mar; 41(3):378-83. PubMed ID: 12605205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.
    EAGLE H; MAGNUSON HJ; FLEISCHMAN R
    J Clin Invest; 1946 Jul; 25(4):451-66. PubMed ID: 21001620
    [No Abstract]   [Full Text] [Related]  

  • 20. Modeling the chelation of As(III) in lewisite by dithiols using density functional theory and solvent-assisted proton exchange.
    Harper LK; Bayse CA
    J Inorg Biochem; 2015 Dec; 153():60-67. PubMed ID: 26479948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.